ANADA Number: 200-316 | |
| Proprietary Name |
Clintabs® |
|---|---|
| Sponsor |
Virbac AH, Inc. |
| Sponsor Address |
3200 Meacham Blvd Ft. Worth, Tx 76137 |
| Ingredients |
Clindamycin Hydrochloride |
| Species |
Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
520.446 Clindamycin hydrochloride capsules and tablets. Specifications: Each tablet contains the equivalent of 25, 75 or 150 milligrams of clindamycin as the hydrochloride salt. Conditions of use: Dogs Amount: Wounds, abscesses, and dental infections: 2.5 to 15 milligrams per pound of body weight every 12 hours for a maximum of 28 days. Osteomyelitis: 5.0 to 15 milligrams per pound of body weight every 12 hours for a minimum of 28 days. Indications: For the treatment of skin infections (wounds and abscesses) due to susceptible strains of coagulase-positive staphylococci (Staphylococcus aureus or S. intermedius), deep wounds and abscesses due to susceptible strains of Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum, and Clostridium perfringens, dental infections due to susceptible strains of S. aureus, B. fragilis, P. melaninogenicus, F. necrophorum, and C. perfringens, and osteomyelitis due to susceptible strains of S. aureus, B. fragilis, P. melaninogenicus, F. necrophorum, and C. perfringens. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |